A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)

Condition:   Neuralgia, PostherpeticIntervention:   Drug: MK0686Sponsor:   Merck Sharp & Dohme Corp.Terminated - verified October 2014

Source: ClinicalTrials.gov - January 24, 2006 Category: Research Source Type: clinical trials